CDC issues health advisory on Rocky Mountain spotted fever, 3 die
HQ Team December 9, 2023: The Centers for Disease Control and Prevention (CDC) has issued a health advisory after three people died following.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team December 9, 2023: The Centers for Disease Control and Prevention (CDC) has issued a health advisory after three people died following.
HQ Team December 8, 2023: The USFDA has approved two treatments for sickle cell disease, one of them the first in the US.
HQ Team December 8, 2023: The current global risk from cholera is âvery highâ with vaccines running short of demand, the World Health.
HQ Team December 8, 2023: A record number of 2,456 fuel lobbyists, tied to the worldâs biggest polluting oil and gas firms and.
HQ Team December 7, 2023: Global nations have raised $83.3 billion so far for financing climate change, according to COP28, the UN Climate.
HQ Team December 7, 2023: AbbVie Inc., will buy Cerevel Therapeutics, developing drugs for neuroscience diseases, for $8.7 billion in a bid to.
HQ Team December 7, 2023: About 40 million women, or one-third, were likely to have a long-term childbirth-related health problem, which is often.
HQ Team December 7, 2023: Climate funds sanctioned by nations globally for Indigenous Peoples and local communities tend to âevaporateâ when channelled through.
HQ Team December 6, 2023: The ongoing annual UN climate conference in Dubai, COP28, must deliver a bullet train to speed up climate.
HQ Team December 6, 2023: Pfizer and Valneva SE announced that they have finalized enrolment in the VALOR Phase III trial of their.